BioLineRx Financial Statements From 2010 to 2026
| BLRX Stock | USD 2.88 0.08 2.86% |
Check BioLineRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLineRx's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioLineRx financial statements analysis is a perfect complement when working with BioLineRx Valuation or Volatility modules.
BioLineRx | Build AI portfolio with BioLineRx Stock |
BioLineRx Company Operating Margin Analysis
BioLineRx's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BioLineRx Operating Margin | (7.58) % |
Most of BioLineRx's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioLineRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, BioLineRx has an Operating Margin of -7.5757%. This is 78.4% lower than that of the Biotechnology sector and 93.24% lower than that of the Health Care industry. The operating margin for all United States stocks is 37.49% higher than that of the company.
BioLineRx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioLineRx's current stock value. Our valuation model uses many indicators to compare BioLineRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioLineRx competition to find correlations between indicators driving BioLineRx's intrinsic value. More Info.BioLineRx is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioLineRx's earnings, one of the primary drivers of an investment's value.About BioLineRx Financial Statements
BioLineRx investors use historical fundamental indicators, such as BioLineRx's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioLineRx. Please read more on our technical analysis and fundamental analysis pages.
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modiin, Israel. Biolinerx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.